How should DSM-V criteria for schizophrenia include cognitive impairment?

Schizophrenia Bulletin

Volumn 33, Issue 4, 2007, Pages 912-920

  Keefe, Richard S E ^a   Fenton, Wayne S ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Cognition; Diagnosis; Schizophrenia

Indexed keywords

COGNITION; COGNITIVE DEFECT; COGNITIVE THERAPY; CONFERENCE PAPER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; EDUCATION; FAMILY HISTORY; HEALTH EDUCATION; HUMAN; MENTAL HEALTH; MOOD DISORDER; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; SCHIZOPHRENIA; SOCIOECONOMICS;

COGNITION DISORDERS; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EDUCATIONAL STATUS; HUMANS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 34547664796     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbm046     Document Type: Conference Paper

References (44)

1. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004;72:29-39.
2. Saykin AJ, Shtasel DL, Gur RE, et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry. 1994;51:124-131.
3. Keefe RSE, Bilder RM, Harvey PD, et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology. 2006;31:2033-2046.
4. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull. 2000;26:119-136.
5. Bryson G, Bell MD. Initial and final work performance in schizophrenia: cognitive and symptom predictors. J Nerv Ment Dis. 2003;191:87-92.
6. Harvey PD, Howanitz E, Parrella M, et al. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am J Psychiatry. 1998;155:1080-1086.
7. Hyman SE, Fenton WS. Medicine. What are the right targets for psychopharmacology? Science. 2003;299:350-351.
8. Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophr Res. 2004;72:21-28.
9. Davidson M, Keefe RSE. Cognitive impairment as a target for pharmacological treatment in schizophrenia. Schizophr Res. 1995;17:123-129.
10. Buchanan RW, Davis M, Goff D, et al. A summary of the FDA-NIMH-MATRICS workshop on clinical trial designs for neurocognitive drugs for schizophrenia. Schizophr Bull. 2005;31:5-21.
11. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. American Psychiatric Association, Inc., Arlington, VA 2000.
12. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003;160:4-12.
13. Krabbendam L, Arts B, van Os J, Aleman A. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr Res. 2005;80:137-149.
14. Zakzanis KK, Leach L, Kaplan E. On the nature and pattern of neurocognitive function in major depressive disorders. Neuropsychiatry Neuropsychol Behav Neurol. 1998;11:111-119.
15. van Gorp WG, Altshuler L, Theberge DC, Wilkins J, Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. Arch Gen Psychiatry. 1998;55:41-46.
16. Harvey PD, Docherty NM, Serper MR, Rasmussen M. Cognitive deficits and thought disorder: II. An 8-month followup study. Schizophr Bull. 1990;16:147-156.
17. Albus M, Hubmann W, Wahlheim C, Sobizack N, Franz U, Mohr F. Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and firstepisode affective disorders. Acta Psychiatr Scand. 1996;94:87-93.
18. Addington J, Addington D. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophr Res. 2000;44:47-56.
19. Hughes C, Kumari V, Soni W, et al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr Res. 2003;59:137-146.
20. Strauss ME. Relations of symptoms to cognitive deficits in schizophrenia. Schizophr Bull. 1993;19:215-231.
21. Bilder RM, Goldman RS, Robinson D, et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry. 2000;157:549-559.
22. Randolph C. RBANS Manual-Repeatable Battery for the Assessment of Neuropsychological Status. PAR, Inc., Lutz, FL. 1998.
23. Wilk CM, Gold JM, Humber K, Dickerson F, Fenton WS, Buchanan RW. Brief cognitive assessment in schizophrenia: normative data for the repeatable battery for the assessment of neuropsychological status. Schizophr Res. 2004;70:175-186.
24. Bryson GJ, Silverstein ML, Nathan A, Stephen L. Differential rate of neuropsychological dysfunction in psychiatric disorders: comparison between the Halstead-Reitan and Luria-Nebraska batteries. Percept Mot Skills. 1993;76:305-306.
25. Heinrichs RW, Awad AG. Neurocognitive subtypes of chronic schizophrenia. Schizophr Res. 1993;9:49-58.
26. Palmer BW, Heaton RK, Paulsen JS, et al. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology. 1997;11:437-446.
27. Keefe RS, Eesley CE, Poe MP. Defining a cognitive function decrement in schizophrenia. Biol Psychiatry. 2005;57:688-691.
28. Cannon M, Caspi A, Moffitt TE, et al. Evidence for earlychildhood, pan-developmental impairment specific to schizophreniform disorder: Results from a longitudinal birth cohort. Arch Gen Psychiatr. 2002;59:449-456.
29. Fuller R, Nopoulos P, Arndt S, O'Leary D, Ho BC, Andreasen NC. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatry. 2002;159:1183-1189.
30. Reichenberg A, Weiser M, Rapp MA, et al. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry. 2005;62:1297-1304.
31. Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Kaplan Z, Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry. 1999;156:1328-1335.
32. Brewer WJ, Wood SJ, McGorry PD, et al. Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry. 2003;160:1790-1794.
33. Brewer WJ, Francey SM, Wood SJ, et al. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry. 2005;162:71-78.
34. Keefe RSE, Perkins DO, Gu H, Zipursky RB, Christensen BK, Lieberman JA. A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophr Res. In press.
35. Bowie CR, Reichenberg A, Patterson TL, Heaton RK, Harvey PD. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, function, functional capacity, and symptoms. Am J Psychiatry. 2006;163:418-425.
36. Keefe RSE, Poe M, Walker TM, Kang JW, Harvey PD. The Schizophrenia Cognition Rating Scale (SCoRS): interview-based assessment and its relationship to cognition, real-world functioning and functional capacity. Am J Psychiatry. 2006;163:426-432.
37. Ventura J, Bilder R, Cienfuegos A, Boxer O. Interview based measures of cognition in schizophrenia. Biol Psychiatry. 2006;59:1715.
38. Mortiz S, Ferahli S, Naber D. Memory and attention performance in psychiatric patients: lack of correspondence between clinician-rated and patient-rated functioning with neuropsychological test results. J Int Neuropsychol Soc. In press.
39. van den Bosch RJ, Rombouts RP. Causal mechanisms of subjective cognitive dysfunction in schizophrenic and depressed patients. J Nerv Ment Dis. 1998;186:364-368.
40. Harvey PD, Serper MR, White L, et al. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia. Compr Psychiatry. 2001;42:306-313.
41. Stip E, Caron J, Renaud S, Pampoulova T, Lecomte Y. Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia. Compr Psychiatry. 2003;44:331-340.
42. Spitzer RL. Values and assumptions in the development of DSM-III and DSM-III-R: an insider's perspective and a belated response to Sadler, Hulgus, and Agich's "On values in recent American psychiatric classification". J Nerv Ment Dis. 2001;189:351-359.
43. Carpenter WT. Schizophrenia: diagnostic class or domains of pathology. Schizophr Bull. 2007;33:203.
44. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12:426-445.